ReviewClinical microbiology reviews2004
Salmonella enterica serotype Choleraesuis: epidemiology, pathogenesis, clinical disease, and treatment.
Review in Clinical microbiology reviews, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 107 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
107 citing papers in PubMed, 1 synthesis or guideline pooled it, 292 citations in OpenAlex.
- Nontyphoidal Salmonella as a Rare Cause of UTI: A Case Report, Systematic Review, and Analysis of Surveillance Data.International urogynecology journal · 2025Pooled it
- Article
- Hyper-rapid progression in Salmonella-associated mycotic aortic aneurysms: a narrative review.Radiology and oncology · 2026Review
- Aortoesophageal fistula as a late-onset complication of infected aortic arch aneurysm caused by Salmonella enterica serotype Choleraesuis: a case report.BMC infectious diseases · 2026Article
- Combination of trained immunity and specific inactivated vaccine againstFrontiers in veterinary science · 2026Article
- Two-Stage Revision Arthroplasty forCase reports in orthopedics · 2026Article
- Antibacterial and Antibiotic Potentiation Activities of Selected Australian Terminalia spp. Against Gastrointestinal Pathogens.Chemistry & biodiversity · 2026Article
- Investigation of Antimicrobial Resistance Genes and Clonal Relatedness of Outbreak-AssociatedInfection and drug resistance · 2026Article
- Microbiological control project of minced meat of wild boar (Sus scrofa L.) in approved establishments in Sweden.Acta veterinaria Scandinavica · 2025Article
- Disinfectants and one health review: The role of reactive oxygen species in the bactericidal activity of chlorine againstOne health (Amsterdam, Netherlands) · 2025Review
- Roles of SPI-2 T3SS effectors in virulence ofFrontiers in veterinary science · 2025Article
- Lung microbiota of raccoon dogs (Frontiers in microbiology · 2025Article
- Royal jelly acid: preparation, metabolism and therapeutic potential.Frontiers in pharmacology · 2025Review
- Infection biology ofEcoSal Plus · 2024Review
- Growth Effects as a Function of pH and Temperature ofIndian journal of microbiology · 2024Article
- Centralized industrialization of pork in Europe and America contributes to the global spread of Salmonella enterica.Nature food · 2024Article
- Article
- Multi-drug-resistant Escherichia coli in adult male patients with enlarged prostate attending general hospitals in Benue state.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2024Article
- Chest wall abscess and costochondritis due to Salmonella enterica serotype Choleraesuis: a case report.Journal of medical case reports · 2023Article
- Development of recombinant subunit vaccine targeting InvH protein of Salmonella Typhimurium and evaluation of its immunoprotective efficacy against salmonellosis.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2023Article
47 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nontyphoid Salmonella strains are important causes of reportable food-borne infection. Among more than 2,000 serotypes, Salmonella enterica serotype Choleraesuis shows the highest predilection to cause systemic infections in humans. The most feared complication of serotype Cholearesuis bacteremia in adults is the development of mycotic aneurysm, which previously was almost uniformally fatal. The advances in diagnostic techniques, surgical care, and antimicrobial therapy have greatly improved the survival of these patients. However, the recent emergence of serotype Choleraesuis that is resistant to ampicillin, chloramphenicol, trimethoprim-sulfamethoxazole, and, notably, fluoroquinolone antibiotics has aroused concern about the use of these agents for the empirical treatment of systemic infection caused by this organism. In view of the serious implications of the situation, the chain of transmission and mechanism of resistance should be carefully studied to reduce the spread of infection and threat to human health. To date, there are no vaccines available to prevent serotype Choleraesuis infections in humans. The availability, in the near future, of the genome sequence of serotype Cholearesuis will facilitate the development of effective vaccines as well as the discovery of new targets for novel antimicrobial agents.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.